Shanghai Fosun Pharmaceutical (Group) Co Ltd 2023 Sustainability Report
Company: Shanghai Fosun Pharmaceutical (Group) Co Ltd
Sector: Manufacturing
Country: China
Year: 2023
Type: Sustainability Report
Pages: 137
The report highlights Fosun Pharma's commitment to innovation-driven high-quality development, focusing on unmet clinical needs and healthcare accessibility. Key achievements in 2023 include the inclusion of several innovative drugs in the National Medical Insurance Drug Catalogue and the WHO prequalification of the second-generation artesunate for injection. The company established a Carbon Neutrality Committee to oversee its "dual carbon" strategy, successfully meeting its 2023 targets for carbon emission and energy consumption intensity. Furthermore, Fosun Pharma demonstrated social responsibility through the "Rural Doctor Project" and "Pink Blue Ribbon Charity Tour," improving healthcare access in underserved regions.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.